These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1556951)

  • 1. Lack of effect of islet amyloid polypeptide on hepatic glucose output in the in situ-perfused rat liver.
    Nishimura S; Sanke T; Machida K; Bessho H; Hanabusa T; Nakai K; Nanjo K
    Metabolism; 1992 Apr; 41(4):431-4. PubMed ID: 1556951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of islet amyloid polypeptide on hepatic insulin resistance and glucose production in the isolated perfused rat liver.
    Roden M; Liener K; Fürnsinn C; Nowotny P; Hollenstein U; Vierhapper H; Waldhäusl W
    Diabetologia; 1992 Feb; 35(2):116-20. PubMed ID: 1312493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet amyloid polypeptide (IAPP/amylin) causes insulin resistance in perfused rat hindlimb muscle.
    Tabata H; Hirayama J; Sowa R; Furuta H; Negoro T; Sanke T; Nanjo K
    Diabetes Res Clin Pract; 1992 Jan; 15(1):57-61. PubMed ID: 1541236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of islet amyloid polypeptide (amylin) and calcitonin gene-related peptide (CGRP) on glucose metabolism in the rat.
    Morishita T; Yamaguchi A; Yamatani T; Nakamura A; Arima N; Yamashita Y; Nakata H; Fujita T; Chiba T
    Diabetes Res Clin Pract; 1992 Jan; 15(1):63-9. PubMed ID: 1541237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Islet amyloid polypeptide (IAPP) does not inhibit glucose-stimulated insulin secretion from isolated perfused rat pancreas.
    O'Brien TD; Westermark P; Johnson KH
    Biochem Biophys Res Commun; 1990 Aug; 170(3):1223-8. PubMed ID: 2202297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory action of islet amyloid polypeptide and calcitonin gene-related peptide on release of insulin from the isolated perfused rat pancreas.
    Kogire M; Ishizuka J; Thompson JC; Greeley GH
    Pancreas; 1991 Jul; 6(4):459-63. PubMed ID: 1876601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The constitutive secretory pathway is a major route for islet amyloid polypeptide secretion in neonatal but not adult rat islet cells.
    Verchere CB; D'Alessio DA; Prigeon RL; Hull RL; Kahn SE
    Diabetes; 2000 Sep; 49(9):1477-84. PubMed ID: 10969831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet amyloid polypeptide decreases the effects of insulin-like growth factor-I on glucose transport and glycogen synthesis in skeletal muscle.
    Dimitriadis G; Crowne E; Clark A; Dunger DB
    Int J Biochem Cell Biol; 1998 Sep; 30(9):1039-46. PubMed ID: 9785467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Islet amyloid polypeptide inhibits insulin secretion in conscious rats.
    Fürnsinn C; Leuvenink H; Roden M; Nowotny P; Schneider B; Rohac M; Pieber T; Clodi M; Waldhäusl W
    Am J Physiol; 1994 Aug; 267(2 Pt 1):E300-5. PubMed ID: 8074211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of islet amyloid polypeptide to inhibit basal and glucose-stimulated insulin secretion in model experiments in mice and rats.
    Pettersson M; Ahrén B
    Acta Physiol Scand; 1990 Mar; 138(3):389-94. PubMed ID: 2183542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets.
    Wang ZL; Bennet WM; Ghatei MA; Byfield PG; Smith DM; Bloom SR
    Diabetes; 1993 Feb; 42(2):330-5. PubMed ID: 8425669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of amidated rat islet amyloid polypeptide on glucose-stimulated insulin secretion in vivo and in vitro in rats.
    Ar'Rajab A; Ahrén B
    Eur J Pharmacol; 1991 Jan; 192(3):443-5. PubMed ID: 2055243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet amyloid polypeptide inhibits glucagon release and exerts a dual action on insulin release from isolated islets.
    Akesson B; Panagiotidis G; Westermark P; Lundquist I
    Regul Pept; 2003 Mar; 111(1-3):55-60. PubMed ID: 12609749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic islet blood flow in the rat after administration of islet amyloid polypeptide or calcitonin gene-related peptide.
    Svensson AM; Sandler S; Jansson L
    Diabetes; 1994 Mar; 43(3):454-8. PubMed ID: 8314019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amylin-induced in vivo insulin resistance in conscious rats: the liver is more sensitive to amylin than peripheral tissues.
    Koopmans SJ; van Mansfeld AD; Jansz HS; Krans HM; Radder JK; Frölich M; de Boer SF; Kreutter DK; Andrews GC; Maassen JA
    Diabetologia; 1991 Apr; 34(4):218-24. PubMed ID: 2065857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homologous islet amyloid polypeptide: effects on plasma levels of glucagon, insulin and glucose in the mouse.
    Panagiotidis G; Salehi AA; Westermark P; Lundquist I
    Diabetes Res Clin Pract; 1992 Dec; 18(3):167-71. PubMed ID: 1337737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newly identified pancreatic protein islet amyloid polypeptide. What is its relationship to diabetes?
    Johnson KH; O'Brien TD; Westermark P
    Diabetes; 1991 Mar; 40(3):310-4. PubMed ID: 1999270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-dependent inhibition of hepatic glycogenolysis by gastric inhibitory polypeptide (GIP) in perfused rat liver.
    Hartmann H; Ebert R; Creutzfeldt W
    Diabetologia; 1986 Feb; 29(2):112-4. PubMed ID: 3516765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IAPP as a regulator of glucose homeostasis and pancreatic hormone secretion (review).
    Karlsson E
    Int J Mol Med; 1999 Jun; 3(6):577-84. PubMed ID: 10341286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic low dose islet amyloid polypeptide infusion reduces food intake, but does not influence glucose metabolism, in unrestrained conscious rats: studies using a novel aortic catheterization technique.
    Arnelo U; Permert J; Larsson J; Reidelberger RD; Arnelo C; Adrian TE
    Endocrinology; 1997 Oct; 138(10):4081-5. PubMed ID: 9322915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.